Chemotherapy Induced Peripheral Neuropathy Market Is Expected To See Huge Growth. Latest Research Report, Forecast 2028

1
Chemotherapy Induced Peripheral Neuropathy Market
Global Analysis and Forecast to 2028

• Published Date May 2022

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com

• Chemotherapy Induced Peripheral Neuropathy Market
  Forecast to 2028 - COVID-19 Impact and Global
  Analysis By Drug Class (Steroids,
  Antidepressants, Anti-Seizure, and Narcotics) and
  Distribution Channel (Retail Pharmacy, Hospital
  Pharmacy, and Online Pharmacy)

3
Chemotherapy Induced Peripheral Neuropathy Market
Overview
Email sales_at_theinsightpartners.com

• The chemotherapy induced peripheral neuropathy
  market is projected to reach US 1,174.26 million
  by 2028 from US 813.48 million in 2021 it is
  expected to register a CAGR of 5.4 from 2021 to
  2028.
• Chemotherapy-induced peripheral neuropathy is one
  of the most frequent side effects caused by
  antineoplastic agents. Clinically, it is a mostly
  sensory neuropathy that may be accompanied by
  motor and autonomic changes of varying intensity
  and duration. Due to its high prevalence among
  cancer patients, chemotherapy-induced peripheral
  neuropathy constitutes a major problem for both
  cancer patients and survivors as well as for
  their health care providers, especially because,
  at the moment, there is no single effective
  method of preventing it moreover, the
  possibilities of treating this syndrome are
  limited.

4
Key Segment Market
Email sales_at_theinsightpartners.com

• Segment By Type-
• By Drug Class (Steroids, Antidepressants,
  Anti-Seizure, and Narcotics)
• Distribution Channel (Retail Pharmacy, Hospital
  Pharmacy, and Online Pharmacy)

Download Sample Here
5
Chemotherapy Induced Peripheral Neuropathy Market
Value
Email sales_at_theinsightpartners.com

• CAGR of 5.4
• (2021 - 2028)

Download Sample
6
Company Profiles
Email sales_at_theinsightpartners.com

• Regenacy Pharmaceuticals, Inc.
• Asahi Kasei Pharma Corporation
• Novaremed
• Makscientific, Llc
• Wex Pharmaceuticals Inc.
• Sova Pharmaceuticals, Inc.
• Kineta, Inc.
• Aptinyx Inc.
• Apexian Pharmaceuticals, Inc.
• Winsantor, Inc.

Download Sample Here
7
By Geography
Email sales_at_theinsightpartners.com

• North America (the US, Canada, and Mexico)
• Europe (the UK, Germany, France, Italy, Spain,
  and the Rest of Europe)
• Asia Pacific (China, Japan, India, Australia,
  South Korea, and the Rest of Asia Pacific)
• Middle East Africa (the UAE, Saudi Arabia,
  South Africa, and the Rest of Middle East
  Africa)
• South Central America (Brazil, Argentina, and
  the Rest of South Central America).

8
THANKYOU!

• Phone  [phone]

• E-Mail sales_at_theinsightpartners.com